Andrew M. Rauth

Publications

• Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia
  Cancer Research. Nov, 2016  |   Pubmed ID: 27758881
• Polymer-lipid Hybrid Nanoparticles Synchronize Pharmacokinetics of Co-encapsulated Doxorubicin-mitomycin C and Enable Their Spatiotemporal Co-delivery and Local Bioavailability in Breast Tumor
  Nanomedicine : Nanotechnology, Biology, and Medicine. Jul, 2016  |   Pubmed ID: 26772427
• Optimization of Controlled Release Nanoparticle Formulation of Verapamil Hydrochloride Using Artificial Neural Networks with Genetic Algorithm and Response Surface Methodology
  European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Aug, 2015  |   Pubmed ID: 25986587
• Manganese Oxide and Docetaxel Co-loaded Fluorescent Polymer Nanoparticles for Dual Modal Imaging and Chemotherapy of Breast Cancer
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Jul, 2015  |   Pubmed ID: 25908171
• Optimizing the Design and in Vitro Evaluation of Bioreactive Glucose Oxidase-microspheres for Enhanced Cytotoxicity Against Multidrug Resistant Breast Cancer Cells
  Colloids and Surfaces. B, Biointerfaces. Jun, 2015  |   Pubmed ID: 25896537
• Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
  Molecular Pharmaceutics. Aug, 2014  |   Pubmed ID: 24830351
• Matrigel Alters the Pathophysiology of Orthotopic Human Breast Adenocarcinoma Xenografts with Implications for Nanomedicine Evaluation
  Nanomedicine : Nanotechnology, Biology, and Medicine. Aug, 2013  |   Pubmed ID: 23434679
• Multifunctional Terpolymeric MRI Contrast Agent with Superior Signal Enhancement in Blood and Tumor
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Apr, 2013  |   Pubmed ID: 23353806
• Doxorubicin and Mitomycin C Co-loaded Polymer-lipid Hybrid Nanoparticles Inhibit Growth of Sensitive and Multidrug Resistant Human Mammary Tumor Xenografts
  Cancer Letters. Jul, 2013  |   Pubmed ID: 22902994
• Evaluation of New Bi-functional Terpolymeric Nanoparticles for Simultaneous in Vivo Optical Imaging and Chemotherapy of Breast Cancer
  Drug Delivery and Translational Research. Dec, 2012  |   Pubmed ID: 25787324
• A Novel Nanoparticle Formulation Overcomes Multiple Types of Membrane Efflux Pumps in Human Breast Cancer Cells
  Drug Delivery and Translational Research. Apr, 2012  |   Pubmed ID: 25786718
• A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor α(v) β(3) Integrin Receptors Reveals Cyclic RGD As a Double-edged Sword
  Advanced Healthcare Materials. Sep, 2012  |   Pubmed ID: 23184795
• Térmicamente Activadas 'off-on-off' Respuesta De Nanopartículas Híbrido De Gadolinio-hidrogel-lípidos Define Una Ventana De Temperatura Personalizable Para Termometría De Resonancia Magnética Nuclear No Invasiva
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Feb, 2012  |   Pubmed ID: 21939700
• A Novel Doxorubicin-mitomycin C Co-encapsulated Nanoparticle Formulation Exhibits Anti-cancer Synergy in Multidrug Resistant Human Breast Cancer Cells
  Breast Cancer Research and Treatment. Jan, 2010  |   Pubmed ID: 19221875
• Molecular Interactions, Internal Structure and Drug Release Kinetics of Rationally Developed Polymer-lipid Hybrid Nanoparticles
  Journal of Controlled Release : Official Journal of the Controlled Release Society. May, 2008  |   Pubmed ID: 18406489
• On the Synergistic Effect of Doxorubicin and Mitomycin C Against Breast Cancer Cells
  Drug Metabolism and Drug Interactions. 2007  |   Pubmed ID: 18447000
• Chemotherapy with Anticancer Drugs Encapsulated in Solid Lipid Nanoparticles
  Advanced Drug Delivery Reviews. Jul, 2007  |   Pubmed ID: 17532091
• Screening of Lipid Carriers and Characterization of Drug-polymer-lipid Interactions for the Rational Design of Polymer-lipid Hybrid Nanoparticles (PLN)
  Pharmaceutical Research. Aug, 2006  |   Pubmed ID: 16850265
• A New Polymer-lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-resistant Human Breast Cancer Cells
  Pharmaceutical Research. Jul, 2006  |   Pubmed ID: 16786442
• A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-lipid Hybrid Nanoparticle System
  The Journal of Pharmacology and Experimental Therapeutics. Jun, 2006  |   Pubmed ID: 16547167
• In Vitro Toxicity to Breast Cancer Cells of Microsphere-delivered Mitomycin C and Its Combination with Doxorubicin
  European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. Apr, 2006  |   Pubmed ID: 16330194
• Biodegradable Dextran-based Microspheres for Delivery of Anticancer Drug Mitomycin C
  Biomaterials. Sep, 2005  |   Pubmed ID: 15814136
• Prediction of Kinetics of Doxorubicin Release from Sulfopropyl Dextran Ion-exchange Microspheres Using Artificial Neural Networks
  European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences. Apr, 2005  |   Pubmed ID: 15784330
• In Vivo Efficacy and Toxicity of Intratumorally Delivered Mitomycin C and Its Combination with Doxorubicin Using Microsphere Formulations
  Anti-cancer Drugs. Apr, 2005  |   Pubmed ID: 15746579
• A New Approach to the in Vivo and in Vitro Investigation of Drug Release from Locoregionally Delivered Microspheres
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2004  |   Pubmed ID: 15491816
• Delivery of an Anticancer Drug and a Chemosensitizer to Murine Breast Sarcoma by Intratumoral Injection of Sulfopropyl Dextran Microspheres
  The Journal of Pharmacy and Pharmacology. Aug, 2003  |   Pubmed ID: 12956895